Eosinophilic Inflammation
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 17311
Special Issue Editors
Interests: allergy; allergic rhinitis; asthma; eosinophils
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
The focus of this Special Issue is eosinophilic inflammation such as allergic rhinitis, asthma, chronic rhinosinusitis with nasal polyp, esophagitis, gastroenteritis, and otitis media.
Eosinophils are key contributors to Th2-associated pathologies such as allergic disorders. They also function as effectors in the innate immune response through the expression of Toll-like receptors. In the inflamed site, activated eosinophils exert their effects through cytotoxic mediators, comprising granules (EPO, MBP, ECP, and EDN), cytokines, chemokines, and lipid mediators, resulting in tissue damage. However, little is known about the mechanisms of pathogenesis by activated eosinophils.
Here, we focus not only all clinical investigations involved in eosinophils-derived disorders but also basic on investigations in vitro and in vivo using animal models.
Prof. Dr. Akira Kanda
Dr. David Dombrowicz
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- airway inflammation
- allergic rhinitis
- asthma
- chronic rhinosinusitis with nasal polyp
- eosinophil
- esophagitis
- gastroenteritis
- otitis media
- united airway disease
- atopic dermatitis
- airway hyperresponsiveness (AHR)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.